Eulerpool Terminal
The edge that pays for itself.
Current Recursion Pharmaceuticals forecasts and price targets in August 2026
Ø Analyst Price Targets
7.14 USD
+134.87 %
Median
7.14 USD
+134.87 %
Max
11.55 USD
Min
3.03 USD
Last Price
3.04 USD
Buy
8
Hold
6
Sell
0
The average target price for Recursion Pharmaceuticals is 7.14 USD. (+134.87 % above the current price)
The median price target of Recursion Pharmaceuticals is 7.14 USD.
Stock analysts from many renowned investment banks are closely examining the Recursion Pharmaceuticals stock. They conclude their professional Recursion Pharmaceuticals stock analyses with a clear recommendation for the Recursion Pharmaceuticals stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 8 | 6 | 0 | 7.14 USD |
| 2026-01-01 | 8 | 6 | 0 | 7.14 USD |
| 2025-12-01 | 7 | 7 | 0 | 7.14 USD |
| 2025-12-01 | 7 | 7 | 0 | 6.46 USD |
| 2025-11-01 | 7 | 7 | 0 | 6.46 USD |
| 2025-11-01 | 7 | 7 | 0 | 6.60 USD |
Recursion Pharmaceuticals Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Recursion Pharmaceuticals in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 59.00 M USD | -480.00 M USD | -0.91 USD |
| 2027e | 83.00 M USD | -482.00 M USD | -0.92 USD |
| 2028e | 153.00 M USD | -395.00 M USD | -0.75 USD |